| Literature DB >> 27411459 |
Lei Yan1, Chun-Rong Wu2, Chen Wang3, Chun-Hui Yang2, Guang-Zhi Tong4, Jian-Guo Tang2.
Abstract
BACKGROUND: Inflammation is supposed to play a key role in the pathophysiological processes of intestinal ischemia-reperfusion injury (IIRI), and Candida albicans in human gut commonly elevates inflammatory cytokines in intestinal mucosa. This study aimed to explore the effect of C. albicans on IIRI.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27411459 PMCID: PMC4960961 DOI: 10.4103/0366-6999.185862
Source DB: PubMed Journal: Chin Med J (Engl) ISSN: 0366-6999 Impact factor: 2.628
Figure 1Histologic changes of intestinal mucosa and injury score. a-e: HE staining (Original magnification × 100). BS: Blank and sham (a); BI: Blank plus intestinal ischemia-reperfusion (b); CI: Cefoperazone plus intestinal ischemia-reperfusion (c); CCI: Candida albicans plus cefoperazone and intestinal ischemia reperfusion injury (d); CCS: Candida albicans plus cefoperazone and sham (e); Intestinal C. albicans hypha is emphasized by arrow. *P < 0.05 compared with group BS; †P < 0.05 compared with group CCS; ‡P < 0.05 compared with group CCI (f).
Figure 2Candida albicans increased the local and systemic inflammatory response after IIRI. Serum and intestine levels of TNF-α (a,b), IL-6 (e,f), and IL-1β (c,d) were determined by ELISA after operation, *P < 0.01 compared with group BS; †P < 0.05 compared with group CCS; ‡P < 0.05 compared with group CCI. CCI: Candida albicans plus cefoperazone and intestinal ischemia-reperfusion injury; BS: Blank and sham; CCS: Candida albicans plus cefoperazone and sham; IIRI: Intestinal ischemia-reperfusion injury; TNF-α: Tumor necrosis factor-α; IL: Interleukin; ELISA: Enzyme-linked immunosorbent assay.
Figure 3Candida albicans elevated DAO in serum (a) and intestine (b). *P < 0.01 compared with group BS; †P < 0.05 compared with group CCS; ‡P < 0.05 compared with group CCI. CCI: Candida albicans plus cefoperazone and intestinal ischemia-reperfusion injury; BS: Blank and sham; CCS: Candida albicans plus cefoperazone and sham; DAO: Diamine oxidase.
Figure 4Presence of Candida albicans in gut and blood. The disruption of intestinal mucosa after IIRI facilitated Candida albicans blood translocation. The incidence of Candida albicans blood invasion was closely related to fungal load in the gut. IIRI: Intestinal ischemia-reperfusion injury.
Candida albicans load in blood and intestine (n = 10, each)
| Group | Blood (×103 CFU/ml) | Intestine (×106 CFU/g) |
|---|---|---|
| CCI | 33.80 ± 6.60 | 22.0 ± 7.3 |
| CCS | 0.14 ± 0.07 | 14.4 ± 6.9 |
| CI | 2.26 ± 1.09 | 0.007 ± 0.005 |
| BI | 0 | 0 |
| BS | 0 | 0 |
CCI: Candida albicans plus cefoperazone and intestinal ischemiareperfusion injury; CCS: Candida albicans plus cefoperazone and sham; CI: Cefoperazone plus intestinal ischemia-reperfusion injury; BI: Blank and intestinal ischemia-reperfusion injury; BS: Blank and sham.